Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer

Condition(s) studied

Investigational drug(s) / intervention(s)

Consultation: Consultation in oncology: collection of oncological data and ongoing cancer treatments, clinical exam Consultation in gynecology: collection of gynecological data, contraception and reproductive medicine

Biological Test: Blood test: * FSH, LH, E2 and AMH * 4 tubes of 7 mL

Pelvic Ultrasound: Antral Follicles Count

Study summary

Interventional research with low risks and constraints, prospective and monocentric on the assessment of long-term fertility in patients who underwent an adjuvant sequential chemotherapy with or without a controled ovarian hyperstimulation. This study follows a previous one called NCT 01614704.

Eligibility

Primary outcome measure(s)

• Assessment of fertility in terms of cumulative incidence of long-term pregnancy — 10 years after chemotherapy
  for patients who underwent adjuvant sequential chemotherapy of anthracycline and taxane separately, depending on whether or not they have had Controlled Ovarian Hyperstimulation

Trial sites (1)

More Centre Oscar Lambret trials in France

Other trials for the same condition